AU2001230180A1 - Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof - Google Patents

Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof

Info

Publication number
AU2001230180A1
AU2001230180A1 AU2001230180A AU3018001A AU2001230180A1 AU 2001230180 A1 AU2001230180 A1 AU 2001230180A1 AU 2001230180 A AU2001230180 A AU 2001230180A AU 3018001 A AU3018001 A AU 3018001A AU 2001230180 A1 AU2001230180 A1 AU 2001230180A1
Authority
AU
Australia
Prior art keywords
compounds
same
pharmaceutical agents
agents containing
fused pyrrole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230180A
Inventor
Stefan Laufer
Hans-Gunter Striegel
Karola Tollmann
Susanne Tries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merckle GmbH
Original Assignee
Merckle GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle GmbH filed Critical Merckle GmbH
Publication of AU2001230180A1 publication Critical patent/AU2001230180A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

The present invention relates to fused pyrrole compounds of the formula 1. in which at least one of the radicals R1, R2, R3 is 4-sulphur-substituted phenyl. These compounds are in particular pyrrolizines, indolizines and heteroanalogues having selective inhibitory action on isoenzyme-2 of prostaglandin H synthase (COX-2). The invention also relates to pharmaceutical compositions which contain these compounds; and the use of these compounds for the treatment of disorders of the rheumatic type.
AU2001230180A 2000-01-13 2001-01-12 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof Abandoned AU2001230180A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10001166 2000-01-13
DE10001166A DE10001166A1 (en) 2000-01-13 2000-01-13 Fused pyrrole compounds, pharmaceutical compositions containing them and their use
PCT/EP2001/000332 WO2001051491A1 (en) 2000-01-13 2001-01-12 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof

Publications (1)

Publication Number Publication Date
AU2001230180A1 true AU2001230180A1 (en) 2001-07-24

Family

ID=7627401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230180A Abandoned AU2001230180A1 (en) 2000-01-13 2001-01-12 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof

Country Status (16)

Country Link
US (1) US6936632B2 (en)
EP (1) EP1246825B1 (en)
JP (1) JP2003525875A (en)
KR (1) KR20020081254A (en)
CN (1) CN1191254C (en)
AT (1) ATE256685T1 (en)
AU (1) AU2001230180A1 (en)
CA (1) CA2396413A1 (en)
DE (2) DE10001166A1 (en)
DK (1) DK1246825T3 (en)
ES (1) ES2213102T3 (en)
MX (1) MXPA02006863A (en)
NO (1) NO323238B1 (en)
PT (1) PT1246825E (en)
TR (1) TR200400270T4 (en)
WO (1) WO2001051491A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10004157A1 (en) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik New pyridyl- or pyrimidinyl-substituted bicyclic pyrrole derivatives, are cyclokine release inhibitors useful for treating immune system-related disorders, e.g. cancer, multiple sclerosis or arthritis
US7425573B2 (en) 2001-08-30 2008-09-16 Merckle Gmbh Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232038A (en) * 1979-08-31 1980-11-04 Syntex (U.S.A.) Inc. 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
EP0087629B1 (en) 1982-03-03 1986-01-15 E.I. Du Pont De Nemours And Company Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
US5260451A (en) * 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
CA2152792C (en) 1993-01-15 2000-02-15 Stephen R. Bertenshaw Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5380738A (en) 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5344991A (en) 1993-10-29 1994-09-06 G.D. Searle & Co. 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
US5475018A (en) 1993-11-30 1995-12-12 G. D. Searle & Co. 1,5-diphenyl pyrazole compounds for treatment of inflammation
AU692231B2 (en) 1994-02-10 1998-06-04 G.D. Searle & Co. Substituted spiro compounds for the treatment of inflammation
US5418254A (en) 1994-05-04 1995-05-23 G. D. Searle & Co. Substituted cyclopentadienyl compounds for the treatment of inflammation
DE4419247A1 (en) * 1994-06-01 1995-12-07 Merckle Gmbh New pyrrolizine keto-acid, keto-ester and carboxamide derivs.
DE4419246A1 (en) * 1994-06-01 1995-12-07 Merckle Gmbh New hetero-aryl substd. pyrrolizine derivs.
DE4419315A1 (en) * 1994-06-01 1995-12-07 Merckle Gmbh New hetero- and oxo-pyrrolizine derivs.
US5593994A (en) 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
JPH11507670A (en) * 1995-06-12 1999-07-06 ジー．ディー．サール アンド カンパニー Treatment of inflammation and inflammation-related diseases with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
DE19624289A1 (en) * 1996-06-18 1998-01-02 Merckle Gmbh New fused pyrrolyl (e.g. pyrrolizine) acid, aldehyde or alcohol compounds
DE19624290A1 (en) 1996-06-18 1998-01-02 Merckle Gmbh Pyrrolizine derivatives to lower lipid levels,
AU3953899A (en) * 1998-05-27 1999-12-13 Nippon Shinyaku Co. Ltd. Cyclooxygenase-2 inhibitors
DE19845446A1 (en) 1998-10-02 2000-04-06 Merckle Gmbh New hydroxy, alkoxy, acyloxy and oxo substituted pyrrolizine derivatives useful for treatment of rheumatic and allergic disorders, e.g. psoriasis, urticaria and eczema
DE59908677D1 (en) 1999-11-23 2004-04-01 Merckle Gmbh ANTI-INFLAMMATORY OXO AND HYDROXY DERIVATIVES OF PYRROLIZINES AND THEIR USE IN PHARMACEUTICAL
DE10004157A1 (en) 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik New pyridyl- or pyrimidinyl-substituted bicyclic pyrrole derivatives, are cyclokine release inhibitors useful for treating immune system-related disorders, e.g. cancer, multiple sclerosis or arthritis

Also Published As

Publication number Publication date
CN1191254C (en) 2005-03-02
ATE256685T1 (en) 2004-01-15
NO20023363L (en) 2002-09-10
KR20020081254A (en) 2002-10-26
CN1418217A (en) 2003-05-14
ES2213102T3 (en) 2004-08-16
EP1246825B1 (en) 2003-12-17
US6936632B2 (en) 2005-08-30
WO2001051491A1 (en) 2001-07-19
DK1246825T3 (en) 2004-04-13
PT1246825E (en) 2004-04-30
US20040122002A1 (en) 2004-06-24
DE50101187D1 (en) 2004-01-29
TR200400270T4 (en) 2004-03-22
CA2396413A1 (en) 2001-07-19
NO323238B1 (en) 2007-02-05
MXPA02006863A (en) 2004-04-05
EP1246825A1 (en) 2002-10-09
NO20023363D0 (en) 2002-07-12
JP2003525875A (en) 2003-09-02
DE10001166A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AP1860A (en) Aryl fused azapolycyclic compounds.
MXPA03010961A (en) Thiazole compounds useful as inhibitors of protein kinases.
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
AU2002239344A1 (en) Pyrazolopyridines
WO2002096905A8 (en) Thiazole compounds useful as inhibitors of protein kinases
HK1048990A1 (en) Novel compounds.
NO20025601L (en) Arylmethylamine derivatives for use as tryptase inhibitors
NO20024614L (en) N-heterocyclic derivatives such as NOS inhibitors
WO2001087882A3 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
HK1155146A1 (en) Indene derivatives as pharmaceutical agents
WO2002048148A3 (en) Pyrazolopyridine derivatives
NO984470L (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
AU1182702A (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
NO20062710L (en) 1-N-phenylamino-1H-imidazole derivatives and pharmaceutical compositions
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
WO2004075846A3 (en) Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
SE9803773D0 (en) Compounds
IL173629A0 (en) Imidazo(4,5-b) pyridine derivatives and pharmaceutical compositions containing the same
AU2001230180A1 (en) Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
ATE251162T1 (en) TRIAZOLO(4,5-D)PYRIMIDINE COMPOUNDS
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors